Cite

    Park, J. et al. (n.d.). Polymer micelle formulation of proteasome inhibitor carfilzomib as a potential strategy to improve metabolic stability and anti-cancer efficacy in human multiple myeloma and lung cancer. Drug metabolism and pharmacokinetics. 32 (1), pp. S46-. [Online].